Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P N Roset

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Drug and Alcohol Dependence|October 24, 2001
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy malesP N Roset, M Farré, R de la Torre, et al.
Clinical Chemistry|September 25, 2001
Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pHM Navarro, S Pichini, M Farré, et al.
British Journal of Clinical Pharmacology|February 15, 2000
Non-linear pharmacokinetics of MDMA ('ecstasy') in humansR de la Torre, M Farré, J Ortuño, et al.
Arzneimittel-Forschung|April 1, 1997
Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral dosesM Farré, P N Roset, J M Badenas, et al.
Journal of Clinical Psychopharmacology|August 5, 2000
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effectsJ Cami, M Farré, M Mas, et al.
Journal of Analytical Toxicology|April 13, 2001
Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteersR Pacifici, M Farré, S Pichini, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolismM Farré, R de la Torre, M L González, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1997
Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administrationM Farré, P N Roset, M Llorente, et al.
Psychopharmacology|November 13, 2012
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apartA M Peiró, M Farré, P N Roset, et al.
Life Sciences|January 6, 2000
Immunomodulating properties of MDMA alone and in combination with alcohol: a pilot studyR Pacifici, P Zuccaro, M Farré, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Drug and Alcohol Dependence|October 24, 2001
Modulation of rate of onset and intensity of drug effects reduces abuse potential in healthy malesP N Roset, M Farré, R de la Torre, et al.
Clinical Chemistry|September 25, 2001
Usefulness of saliva for measurement of 3,4-methylenedioxymethamphetamine and its metabolites: correlation with plasma drug concentrations and effect of salivary pHM Navarro, S Pichini, M Farré, et al.
British Journal of Clinical Pharmacology|February 15, 2000
Non-linear pharmacokinetics of MDMA ('ecstasy') in humansR de la Torre, M Farré, J Ortuño, et al.
Arzneimittel-Forschung|April 1, 1997
Tolerability and pharmacokinetics of ebrotidine in healthy subjects given single and repeated oral dosesM Farré, P N Roset, J M Badenas, et al.
Journal of Clinical Psychopharmacology|August 5, 2000
Human pharmacology of 3,4-methylenedioxymethamphetamine ("ecstasy"): psychomotor performance and subjective effectsJ Cami, M Farré, M Mas, et al.
Journal of Analytical Toxicology|April 13, 2001
Sweat testing of MDMA with the Drugwipe analytical device: a controlled study with two volunteersR Pacifici, M Farré, S Pichini, et al.
The Journal of Pharmacology and Experimental Therapeutics|October 23, 1997
Cocaine and alcohol interactions in humans: neuroendocrine effects and cocaethylene metabolismM Farré, R de la Torre, M L González, et al.
Methods and Findings in Experimental and Clinical Pharmacology|June 1, 1997
Clinical pharmacokinetics and tolerability of dotarizine in healthy subjects after single and multiple oral administrationM Farré, P N Roset, M Llorente, et al.
Psychopharmacology|November 13, 2012
Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apartA M Peiró, M Farré, P N Roset, et al.
Life Sciences|January 6, 2000
Immunomodulating properties of MDMA alone and in combination with alcohol: a pilot studyR Pacifici, P Zuccaro, M Farré, et al.
Pageof 3